News
Pennington Biomedical Research Institute and Compellis Pharmaceuticals Complete Phase I Study of Obesity Therapy
Compellis Pharmaceuticals, Inc., an early-stage pharmaceutical company
developing novel mechanism-based therapeutics for the treatment of
obesity, announced today with its collaborator Pennington Biomedical
Research Institute at Louisiana State University, that they have
successfully completed a human Phase I pilot clinical trial. Study
subjects were given one of three doses of the drug (CP404) to test
safety, tolerability and impact on smell perception. CP404 is a
calcium channel blocker and has been used in oral dosage form to
Cytomedix Announces LHA Life Sciences & Med Tech Day 2010 Presentation
What: LHA Life Sciences & Med Tech Day 2010 Presentation
When: July 20, 2010 @ 9:00 AM Eastern
Where: investorcalendar.com/ClientPage.asp?ID=160316
How: Live over the Internet -- Simply log on to the web at the address above.
If you are unable to participate during the live webcast, the call will be available for replay at investorcalendar.com.
Wound Management Technologies, Inc. Expands Distribution Channel
Wound Management Technologies, Inc. is pleased to announce another milestone in its planned growth strategy. Its subsidiary, Wound Care Innovations, L.L.C., signed a distribution agreement with Healing Innovation, Ltd. of Belize to facilitate the sale of CellerateRx® in Belize, El Salvador, Honduras, Nicaragua and Guatemala. Healing Innovation has also placed its first stocking order with Wound Care Innovations. Wound Care Innovations' Senior VP of Marketing and Sales, Ron Mathis, is in Belize this week coordinating the Central American product roll-out plans with Healing Innovation. Albert Cattouse, CEO of Healing Innovation was quoted as saying, "We are delighted to have been selected to represent CellerateRx® here in the five countries and are anxious to be receiving the product thus helping the people in this region."
Wound Care Innovations to Launch Direct Response TV Ad Campaign of CellerateRx®
Wound Management Technologies, Inc. announced an important milestone in its planned growth strategy. Its wholly owned subsidiary Wound Care Innovations signed a distribution agreement with KOMED, LLC of Georgia for direct response advertising on television and niche online marketing of CellerateRx® in the United States. TV Goods Holding Corporation (TV Goods), a subsidiary of H&H Imports, Inc., will produce and air the commercials marketing CellerateRx® in cooperation with KOMED, LLC.
HEALTHPOINT, Ltd. Announces New Vice President
HEALTHPOINT, Ltd., a DFB Pharmaceuticals, Inc. company, has announced that Brad Adams has joined the company as Vice President, Sales. Prior to Healthpoint, Mr. Adams achieved international experience in health care sales, marketing and business administration at several Johnson & Johnson affiliate companies.
"I am pleased to welcome Brad on board," said Travis E. Baugh, President and Chief Operating Officer at Healthpoint. "His extensive exposure to and command of every aspect of healthcare business make him a tremendous addition to our team."
N.J. Nursing Homes Have New Weapon to Fight Pressure Ulcers
New Jersey's 360 licensed nursing homes are being equipped with a new resource to help them identify, document and ultimately help prevent pressure ulcers in their elderly and frail residents.
Each facility will receive 10 free copies of the Pocket Guide to Pressure Ulcers, courtesy of the state Department of Health and Senior Services. DHSS is dedicating federal funds allocated by the Centers for Medicare and Medicaid Services through civil monetary penalties to provide the resource.
Infection Surveillance Module Added to Medici Software
Asolva, a provider of healthcare data analytics and reporting systems, has added a package of infection surveillance tools to Medici, its clinical information management system. The package will assist pharmacists, physicians and other infection preventionists in tracking and maximizing their antimicrobial stewardship programs (ASPs).
8th International Conference on Biotherapy
November 11-14, 2010 at the Universal City Hilton in Los Angeles.
Biotherapy is the use of living organisms to treat or diagnose medical illnesses. Examples of medicinal organisms include leeches, fly larvae (maggots), bacteriophage (all used in wound care), along with honey bees, service animals and more.
Prospera® Educational Symposium Redefines Best Practices in NPWT
Prospera Technologies, LLC hosted a major NPWT scientific symposium held April 17, 2010 during the Annual Spring meeting of the Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS), in Orlando, Florida. The unusually comprehensive session, titled “The Evolution of NPWT: Evidence-based Innovations to Optimize Therapy and Avoid Complications,” featured keynote speaker Malin Malmsjo, MD, PhD, and Associate Professor at Lund University, Lund, Sweden. The meeting not only addressed key NPWT variables in light of recent scientific evidence, but also offered extremely practical guidance to the 150 wound care professionals in attendance (physicians, nurses, therapists, and others). Historical gaps in the NPWT evidence base were outlined, followed by a step-by-step review of recent novel studies testing the use of various negative pressure levels, various wound fillers, and different modes of negative pressure delivery (continuous, intermittent, and variable). Claus Brandigi, MD, Associate Director, Joseph M. Still Burn Center, Augusta, Georgia, moderated the session.
Posters Featuring MEDIHONEY® Win Top Honors at Conference
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, announced that two posters featuring MEDIHONEY®, the company's honey-based dressings for the management of wounds and burns, took first and second place in a competition among more than 50 posters on display at the American Professional Wound Care Association's 10th Annual Conference in Philadelphia, which was held April 8-11.